期刊文献+

丰富环境对MPTP致快速老化小鼠脑损伤的干预效应 被引量:1

Intervention effects of enriched environment on brain damage of MPTP-induced senescence-accelerated prone mice
在线阅读 下载PDF
导出
摘要 目的观察丰富环境(EE)对快速老化(SAMP8)小鼠黑质脑源性神经营养因子(BDNF)的影响,探讨EE保护黑质多巴胺神经元降低1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)损伤的机制。方法 80只3个月龄雌性SAMP8小鼠随机分为EE组和标准环境组(SE组)。饲养3个月后,EE组和SE组小鼠分别随机分为MPTP组和生理盐水对照组(NS组),每组20只。MPTP组小鼠皮下注射MPTP(14mg/kg每2h一次,共4次),NS组小鼠皮下注射等量的生理盐水。第7天取鼠脑采用RT-PCR方法观测黑质BDNF mRNA,免疫组织化学方法观察黑质BDNF免疫反应性的表达。结果 EE+NS组与SE+NS组比较,黑质BDNF mRNA表达增加(P<0.01);黑质区BDNF-ir阳性细胞数及矫正光密度(COD)值均增加(P<0.01)。SE+MPTP组与SE+NS组比较,黑质BDNF mRNA表达下降(P<0.001);黑质区BDNF-ir阳性细胞数及COD值均下降(P<0.01)。EE+MPTP组与SE+MPTP组比较,黑质BDNF mRNA表达增加(P<0.01);黑质区BDNF-ir阳性细胞数及COD值均增加(P<0.01)。结论 EE能增加SAMP8小鼠黑质区BDNF mRNA及BDNF-ir的阳性表达,降低MPTP对SAMP8小鼠黑质的损伤,对黑质有保护作用。 Objective To observe the effects of enriched environmen(EE) on brain-derived neurotrophic factor(BDNF) in substantia nigra(SN) of senescence-accelerated prone mice,so as to explore the possible mechanism of EE in alleviating MPTP induced damage and in protecting dopaminergic neurons in the SN.Methods Totally 80 3-month old female SAMP8 mice were averagely assigned to EE and standard environment(SE) groups at random.After three months,the mice in each group were further divided into 2 subgroups at random:MPTP group and NS group(n = 20).The MPTP groups received subcutaneous injection of MPTP,and the NS mice were treated with an equal volume of NS.At the seventh day,the mice were sacrificed for RT-PCR and immunohistochemistry staining.RT-PCR was used to examine BDNF mRNA expression and immunohistochemistry staining was used to examine BDNF-ir expression.Results Compared with SE + NS mice,EE + NS mice had significantly increased BDNF mRNA expression(P 〈 0.01),and the number of BDNF-ir cell and COD values in SN were also significantly increased(P 〈 0.01).Compared with SE + NS mice,SE + MPTP mice showed significantly decreased BDNF mRNA expression(P 〈 0.001),and the number of BDNF-ir cells and the COD values in SN of mice were significantly decreased(P 〈 0.01).Compared with SE + MPTP mice,EE + MPTP mice showed increased BDNF mRNA expression(P 〈 0.01),and the number of BDNF-ir cells and the COD values in SN were significantly increased(P 〈 0.01).Conclusion EE can increase BDNF mRNA expression and BDNF-ir cell number in SN of SAMP8 mice,alleviating MPTP-induced SN damage.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2010年第11期1179-1183,共5页 Academic Journal of Second Military Medical University
基金 河北省自然科学基金(C2009001242) 河北省卫生厅课题(20090338)~~
关键词 丰富环境 1甲基-4-苯基1 2 3 6-四氢吡啶 快速老化小鼠 神经营养因子 enriched environment; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; senescence accelerated mouse; neurotrophic factor
  • 相关文献

参考文献17

  • 1Scalzo P, Kiimmer A, Bretas T L, Cardoso F,Teixeira A L. Serum levels of brain derived neurotrophic factor correlate with motor impairment in Parkinson' s disease[J]. J Neurol, 2010, 257:540-545.
  • 2Yuan Z Y,Gu P,Liu L,Wang Y Y,Liu J,Cui D S,et al. Neuroprotective effects of enriched environment in MPTP-treated SAMP8 mice[J]. Neurosci Lett, 2009,454: 6-10.
  • 3刘静,王彦永,刘力,王全懂,苑振云,张忠霞,王铭维.MPTP对快速老化小鼠黑质纹状体系统的急性损害及小胶质细胞的激活[J].第二军医大学学报,2009,30(2):151-156. 被引量:2
  • 4Liu J,Wang Y Y,I.iu I.,Wang Q D, Yuan Z Y,Zhang Z X,et al. Damage to the nigrostriatal system in the MPTP treated SAMP8 mouse[J]. Neurosci Lett, 2008,448 : 184-188.
  • 5Youdim M B, Maruyama W, Naoi M. Neuropharmacological, neuroprotective and amyloid precursor processing properties of selective MAO-B inhibitor antiparkinsonian drug, rasagiline [J]. Drugs Today (Barc),2005,41:369 391.
  • 6ChenC M,Chen I C,Chang K H,Chen Y C,Lyu R K,Liu Y T,et al. Nuclear receptor NR4A2 IVS6 --18insG and brain derived neurotrophic factor (BDNF) V66M polymorphisms and risk of Taiwan Residents Parkinson's disease [J]. Am J Med Genet B Neuropsychiatr Genet,2007,144B:458- 462.
  • 7Spina M B, Squin*o S P, Miller J, Lindsay R M, Hyman C. Brain derived neurotrophic factor protects dopamine neurons a gainst 6 hydroxydopamine and N-methyl 4 phenylpyridinium ion toxicity:involvement of glutathione system [J]. J Neuro chern, 1992,59 : 99-106.
  • 8Lindsay R M,Wiegand S J ,Altar C A,DiStefano P S. Neurotrophic factors: from molecules to man [J].Trends Neurosci, 1994,17:182-190.
  • 9Chauhan N B,Siegel G J, I.ee J M. Depletion of glial cell linederived neurotrophic factor in substantia nigra neurons of Par kinson's disease brain[J].J Chem Neuroanat, 2001, 21: 277- 288.
  • 10Howells D W,Porriu M J,Wong J Y,Batchelor P E,Kalnins R, Hughes A J,et al. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra [J]. Exp Neurol, 2000, 166:127 -135.

二级参考文献21

  • 1von Bohlen Und Halbach O. Modeling neurodegenerative diseases in vivo review[J]. Neurodegener Dis, 2005,2 : 313-320.
  • 2Melrose H L, Lincoln S J, Tyndall G M, Farter M J. Parkinson' s disease;a rethink of rodent models[J]. Exp Brain Res, 2006,173; 196-204.
  • 3Collier T J,I.ipton J,Daley B F,Palfi S,Chu Y,Sortwell C,et al. Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism[J]. Neurobiol Dis, 2007,26 : 56-65.
  • 4Zhang I.,Li Q,Wolff I. T,Antonio G E,Yeung D K,Zhang A, et al. Changes of brain activity in the aged SAMP mouse[J]. Biogerontology, 2007,8 : 81-88.
  • 5Colas D, Gharib A, BezinL, Morales A, Guidon G, Cespuglio R,et al. Regional age-reLated changes in neuronal nitric oxide synthase (nNOS), messenger RNA levels and activity in SAMP8 brain[J]. BMC Neurosci, 2006,7 : 81.
  • 6Jackson I.ewis V,Przedborski S. Protocol for the MPTP mouse model of Parkinson's disease[J]. Nat Protoc,2007,2: 141-151.
  • 7Herrera A J, Tomas Camardiel M, Venero J I., Cano J, Machado A. Inflammatory process as a determinant factor for the de generation of substantia nigra dopaminergic neurons[J]. J NeuralTransm,2005,112:111-119.
  • 8Watanabe Y, Kato H, Araki T, Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Par kinson's disease[J]. Metab Brain Dis, 2008,23: 51-69.
  • 9Kawasaki T, Ago Y, Kitao T, Nashida T, Takagi A, Takuma K,et al. A neuroprotective agent, T-817MA (1 (3[-2-(1- benzothiophen-5-yl) ethoxy]propyl } azetidin-3-ol maleate), prevents l-methyl-4-phenyl 1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity in mice [J]. Neuropharmacology, 2008, 55 : 654- 660.
  • 10Sugama S, Yang L,Cho B P, DeGiorgio L A, Lorenzl S, Albers D S, et al. Age-related microglial activation in 1 methyl-4-phen- yl 1,2,3,6-tetrahydropyridine ( MPTP)-induced dopaminergic mice[J]. Brain Res,2003,964

共引文献1

同被引文献14

  • 1Pan-Montojo F, Anichtchik 0, Dening Y. Knels L, Pur?sche S,Jung R,et al. Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice[J]. PLoS One,2010,5:e8762.
  • 2Perfeito R, Cunha-Oliveira T, Rego A C. Revisiting oxi?dative stress and mitochondrial dysfunction in the path?ogenesis of Parkinson disease - resemblance to the effect of amphetamine drugs of abuse[J]. Free Radic Bi?oI Med,2012,53:1791-1806.
  • 3Koppula S, Kumar H, More S V, Kim B W, Kim I S, Choi D K. Recent advances on the neuroprotective po?tential of antioxidants in experimental models of Parkin?son's disease[J]. IntJ Mol Sci,2012,13:10608-10629.
  • 4Feng S, Yang Q,Liu M,Li W, Yuan W,Zhang Sv et al. Edaravone for acute ischaemic stroke[J]. Cochrane Da?tabase Syst Rev,2011(l2) :CD007230.
  • 5Lu Fv Nakamura Tv Toyoshima T,Liu Y,Hirooka K, Kawai N, et al. Edaravone , a free radical scavenger, at?tenuates behavioral deficits following transient forebrain ischemia by inhibiting oxidative damage in gerbils[J]. Neurosci Lett,2012,506:28-32.
  • 6Ahmad A, Khan M M,Javed H, Raza S S, Ishrat T, Khan M B, et al, Edaravone ameliorates oxidative stress associated cholinergic dysfunction and limits apoptotic response following focal cerebral ischemia in rat[J]. Mol Cell Biochern , 2012,3670-2) : 215-225.
  • 7Yarnashita Sv Hasuo H,Tokutomi T,Shigemori M,Akasu T. Edaravone attenuates impairment of synaptic plasticity in granule cell layer of the dentate gyrus following traumatic brain injury[J]. Kurume MedJ,2011,58:47-58.
  • 8Arumugam S, Thandavarayan R A, Veeraveedu P T,Naka?mura T, Arozal W, Sari F R, et al. Beneficial effects of edar?avone , a novel antioxidant, in rats with dilated cardiornyopa?thy[J].J Cell Mol Med, 2012,16: 2176-2185.
  • 9Yuan WJ, Yasuhara T, Shingo T, Muraoka K, Agari T, Kameda M, et al. Neuroprotective effects of edara?vone-administration on 6-0HDA-treated dopaminergic neurons[J]. BMC Neurosci,2008,9:75.
  • 10Hurter-SaundersJ A, Gendelman H E, Mosley R L. Murine motor and behavior functional evaluations for a?cute 1-methyl-4-phenyl-1, 2, 3, G-tet rahydropyridine (MPTP) intoxication[J].J Neuroimmune Pharmacol, 2012,7: 279-288.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部